Published in Eur J Pediatr on August 23, 2008
Alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis. Eur J Pediatr (2011) 1.43
Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications. Arch Dis Child Fetal Neonatal Ed (2014) 0.95
Subcutaneous fat necrosis of the newborn: clinical manifestations in two cases. An Bras Dermatol (2013) 0.84
Subcutaneous fat necrosis causing neonatal hypercalcaemia. BMJ Case Rep (2015) 0.79
Neonatal hypercalcemia secondary to subcutaneous fat necrosis successfully treated with pamidronate: a case series and literature review. AJP Rep (2014) 0.79
Zoledronic acid for neonatal subcutaneous fat necrosis. Clin Case Rep (2017) 0.75
Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med (1998) 3.66
Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis. Horm Res (2006) 2.78
Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature. Pediatr Dermatol (1993) 0.97
Sclerema neonatorum and subcutaneous fat necrosis of the newborn. Pediatr Dermatol (1987) 0.95
Neonatal nephrocalcinosis: long term follow up. Arch Dis Child Fetal Neonatal Ed (2006) 0.94
Subcutaneous fat necrosis of the newborn associated with anemia. Pediatr Dermatol (2000) 0.93
Hypercalcemia with increased and unregulated 1,25-dihydroxyvitamin D production in a neonate with subcutaneous fat necrosis. J Pediatr (1988) 0.92
Subcutaneous fat necrosis of the newborn with hypercalcemia. J Am Acad Dermatol (1987) 0.91
Normal subcutaneous fat, necrosis of adipocytes and classification of the panniculitides. Semin Cutan Med Surg (2007) 0.86
The effect of particle size and electrical charge on macrophage-osteoclast differentiation and bone resorption. J Mater Sci Mater Med (2003) 0.85
Subcutaneous fat necrosis of the newborn. A case report. Arch Dermatol (1981) 0.84
High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone. Pediatr Radiol (2003) 0.80
Subcutaneous fat necrosis of the newborn complicated by hypercalcaemia and thrombocytopenia. Australas J Dermatol (1992) 0.75
Post steroid panniculitis. Australas J Dermatol (1986) 0.75
Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect (2008) 1.70
Early morbidity and neurodevelopmental outcome in low-birthweight infants born after third trimester bleeding. Am J Perinatol (1994) 1.42
Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med (2012) 1.06
Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (2009) 0.97
Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin Vaccine Immunol (2009) 0.96
Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis (2001) 0.95
Different maturation of neutrophil chemotaxis in term and preterm newborn infants. J Pediatr (1982) 0.90
Value of antenatal corticosteroid therapy in preterm birth. Early Hum Dev (1995) 0.89
Significance of low birthweight for gestational age among very preterm infants. Br J Obstet Gynaecol (1997) 0.89
Meconium-stained amniotic fluid and risk for cerebral palsy in preterm infants. Obstet Gynecol (1997) 0.87
Effect of preterm premature rupture of membranes on neurodevelopmental outcome: follow up at two years of age. Br J Obstet Gynaecol (1995) 0.86
Recent advances in prevention of sepsis in the premature neonates in NICU. Early Hum Dev (2011) 0.86
Cerebral and somatic rSO2 in sick preterm infants. J Matern Fetal Neonatal Med (2012) 0.85
Lactoferrin and prevention of late-onset sepsis in the pre-term neonates. Early Hum Dev (2010) 0.83
Extracranial radiosurgery: immobilizing liver motion in dogs using high-frequency jet ventilation and total intravenous anesthesia. Int J Radiat Oncol Biol Phys (2001) 0.81
Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol (1998) 0.80
Use and misuse of antibiotics in the neonatal intensive care unit. J Matern Fetal Neonatal Med (2012) 0.80
Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns. J Chemother (2007) 0.80
Histochemistry of the intercellular substance of the normal and psoriatic human epidermis. Arch Dermatol Res (1978) 0.80
Fluconazole use and safety in the nursery. Early Hum Dev (2012) 0.80
Variation of B-type natriuretic peptide concentrations and intrauterine growth restriction: mother, fetus and newborn. J Biol Regul Homeost Agents (2012) 0.79
Pharmacokinetics of antifungal agents in neonates and young infants. Curr Med Chem (2012) 0.79
Infant neurodevelopmental outcome in pregnancies complicated by gestational hypertension and intra-uterine growth retardation. J Perinat Med (1993) 0.78
Escherichia coli specific secretory IgA and cytokines in human milk from mothers of different ethnic groups resident in northern Italy. Int J Immunopathol Pharmacol (2007) 0.78
Antenatal and delivery risk factors simultaneously associated with neonatal death and cerebral palsy in preterm infants. Early Hum Dev (1997) 0.78
Preeclampsia, preterm delivery and infant cerebral palsy. Eur J Obstet Gynecol Reprod Biol (1998) 0.78
[Neonatal sepsis: new preventive strategies]. Minerva Pediatr (2013) 0.77
Rates of neonatal death and cerebral palsy associated with fetal growth restriction among very low birthweight infants. A temporal analysis. BJOG (2006) 0.77
Severity of abruptio placentae and neurodevelopmental outcome in low birth weight infants. Early Hum Dev (1993) 0.77
Epidemiologic association between maternal smoking during pregnancy and intracranial hemorrhage in preterm infants. J Pediatr (1995) 0.77
Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants. Int J Immunopathol Pharmacol (2013) 0.77
Human colostrum T lymphocytes and their effector cytokines actively aid the development of the newborn immune system. Int J Immunopathol Pharmacol (2009) 0.77
Application and evaluation of a classification system and case definitions of Toxoplasma gondii infection. Eur J Clin Microbiol Infect Dis (1998) 0.77
Preterm newborns are provided with triggering receptor expressed on myeloid cells-1. Int J Immunopathol Pharmacol (2011) 0.77
Circulating endothelial progenitor cells and diseases of the preterm infant. Minerva Pediatr (2010) 0.77
[Changes in circulating levels of adiponectin and leptin in children during the first two years of life]. Minerva Pediatr (2007) 0.77
Neonatal cutaneous disseminated aspergillosis in a preterm extremely-low-birth-weight infant with favourable outcome at 3-year follow-up: a case report. Early Hum Dev (2012) 0.76
Complement-dependent bactericidal activity for E. coli K12 in serum of preterm newborn infants. Acta Paediatr Scand (1987) 0.76
Response to pain in a group of healthy term newborns: behavioral and physiological aspects. Funct Neurol (1996) 0.76
Pigmented BCC and LMM in a single lesion. J Dermatol Surg Oncol (1989) 0.76
Cord blood, perinatal BNP values in term and preterm newborns. Arch Dis Child Fetal Neonatal Ed (2010) 0.76
Clinical characteristics and response to prophylactic fluconazole of preterm VLBW neonates with baseline and acquired fungal colonisation in NICU: data from a multicentre RCT. Early Hum Dev (2012) 0.76
[Antibiotherapy as first choice in neonatal septicemia]. Arch Fr Pediatr (1992) 0.75
Histochemistry of the dermal ground substance of initial psoriatic lesions. Arch Dermatol Res (1978) 0.75
[Isotretinoin in the therapy of severe polymorphous acne. Preliminary data]. G Ital Dermatol Venereol (1986) 0.75
Early neonatal complications after elective preterm delivery in hypertensive pregnancies. J Perinat Med (1995) 0.75
[Evaluation of the clinico-bacteriologic efficacy and tolerance of netilmicin in the treatment of neonatal staphylococcal infections]. G Ital Chemioter (1989) 0.75
Stem cells for bronchopulmonary dysplasia and intraventricular haemorrhage repair in preterm infants. Early Hum Dev (2012) 0.75
[Therapy of penile viral condylomata with 0.5% podophyllotoxin]. G Ital Dermatol Venereol (1990) 0.75
Correct choices for correct treatments: key issues in the management of Candida infections in preterm neonates. Early Hum Dev (2012) 0.75
HIV-specific IgG3 in cord blood. Predictive value for seroreversion. Ann N Y Acad Sci (1993) 0.75
[Surveillance of infection events in neonatal intensive care]. Minerva Pediatr (2010) 0.75
[Risk factors in maternal-fetal infections. Research conducted in 93 cases]. Boll Ist Sieroter Milan (1982) 0.75
Antibiotics in neonatal intensive care units (NICUs). J Chemother (2007) 0.75
A simple modification of the intermittent gavage feeding technique in low-birth-weight infants. Pediatrics (1982) 0.75
[Congenital toxoplasmosis: laboratory diagnosis]. Pediatr Med Chir (2003) 0.75
Clinical use of lactoferrin in preterm neonates: an update. Minerva Pediatr (2010) 0.75
[Follow-up of the neonate at risk between hospital and territory: neonates with congenital infections]. Minerva Pediatr (2007) 0.75
Development and validation of an enzyme linked immunosorbent assay for palivizumab serum determination. Int J Immunopathol Pharmacol (2013) 0.75
[Penile lesions induced by human papillomavirus. An immunohistochemical study and DNA hybridization]. G Ital Dermatol Venereol (1990) 0.75
Hemodynamic management of the preterm infant with acute respiratory failure: role of the functional echocardiography. Acta Biomed (2015) 0.75
[Congenital cytomegalovirus infection]. Minerva Pediatr (2005) 0.75
[Sweet syndrome with exclusive skin manifestations]. G Ital Dermatol Venereol (1988) 0.75
Usefulness of etretinate treatment in paraneoplastic plamoplantar hyperkeratosis. Br J Dermatol (1987) 0.75
[Malignant acanthosis nigricans with an unusual clinical expression]. G Ital Dermatol Venereol (1985) 0.75
[Update for the standard procedures of diagnosis and therapy in cases of congenital rubella]. Pediatr Med Chir (2013) 0.75
Chronic bullous dermatosis of childhood. Acta Derm Venereol (1979) 0.75
[Neonatal systemic infections caused by Candida albicans]. Minerva Pediatr (1986) 0.75
The influence of presentation and method of delivery on neonatal mortality and infant neurodevelopmental outcome in nondiscordant low-birthweight ( < 2500 g) twin gestations. Eur J Obstet Gynecol Reprod Biol (1992) 0.75
[Epidemiologic observations on Chlamydia trachomatis infections]. Boll Ist Sieroter Milan (1983) 0.75
[Epidemic caused by Serratia marcescens in a neonatal intensive care center]. G Ital Chemioter (1983) 0.75
Kaposi's sarcoma complicating immunosuppressive therapy for angioimmunoblastic lymphadenopathy with dysproteinemia. Tumori (1982) 0.75
[Standard procedures for the diagnosis and management of cases of congenital rubella]. Pediatr Med Chir (2004) 0.75
Congenital cystic adenomatoid malformation of the lung. Presentation of 16 cases. Rofo (1989) 0.75
[Pharmacokinetics of ceftriaxone in the first three month of life]. Pediatr Med Chir (1992) 0.75
[Bifonazole in the treatment of dermatitis seborrheica]. G Ital Dermatol Venereol (1988) 0.75
[Neuropsychologic development of small for gestational age preterm infants: follow up at 12-36 months of age]. Pediatr Med Chir (1993) 0.75
Acid mucopolysaccharides of the dermis in incipient psoriasis. Acta Derm Venereol Suppl (Stockh) (1979) 0.75
Rapid control of two outbreaks of Serratia marcescens in a Northern Italian neonatal intensive care unit. J Chemother (2007) 0.75